FindTrial
Sign In

KD-370 Phase II study.

KD-370 Phase II study.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222866
Enrollment
Unknown
Registered
2015-05-26
Start date
2015-05-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.

Interventions

investigational material(s) Generic name etc : KD-370 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : 0.5 mL, Four

Sponsors

The Chemo-Sero-Therapeutic Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: More than 2 months old, less than 60 months old

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026